[ad_1]
The National Immunization Advisory Committee (NIAC) recommended that the AstraZeneca vaccine be used for people age 70 and older, in new advice to the Department of Health.
He has also said that there should be no delays in vaccination.
The new recommendation may clear the way for the use of the AstraZeneca vaccine in this group of older people.
So far, more than 100,000 people in this age group have received a first dose, primarily the Pfizer vaccine.
But there are a total of about half a million people in Cohort 3, those aged 70 and over, who need to be vaccinated.
The new council updates the original NIAC advice on February 2, which recommended that the AstraZeneca vaccine could be used for people 65 and older, but when possible and timely, an mRNA vaccine such as Pfizer or Moderna should be used.
After receiving that advice, Medical Director Dr. Tony Holohan recommended to the government that the AstraZeneca vaccine not be used in people 70 years of age or older.
Deputy CMO Dr. Ronan Glynn is expected to provide a revised vision to the government shortly, after receiving the new recommendation from CANI.
The CANI provides its advice to the CMO on vaccines and the CMO then informs the Government.
Latest coronavirus stories
[ad_2]